featured
Improved Survival in Patients With HR+/HER2– Metastatic Breast Cancer Treated With Initial Endocrine Therapy vs Initial Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Survival in Patients With HR+/HER2– Metastatic Breast Cancer Treated With Initial Endocrine Therapy Versus Initial Chemotherapy. A French Population-Based Study
Br. J. Cancer 2020 Jul 17;[EPub Ahead of Print], J Simon, M Chaix, O Billa, AM Kamga, P Roignot, S Ladoire, C Coutant, P Arveux, C Quantin, TS Dabakuyo-YonliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.